Legend Capital

Legend Capital is a Beijing-based venture capital firm and subsidiary of Legend Holdings. Founded in 2001, it focuses on early-stage and growth investments in technology-driven sectors with operations anchored in China and related markets. The firm backs companies in IT, internet applications and services, outsourcing, IC design and key components, as well as sectors such as telecommunications, media, healthcare, consumer and intelligent manufacturing. It manages multiple funds and actively supports portfolio companies with business development, market positioning and access to Chinese markets to create value. Legend Capital aims to back high-growth ventures and build lasting value in China's venture capital ecosystem.

Daqing Cai

Managing Director

Rui Chen

Managing Director

Chen Hao

Vice Chairman

FAN Qihui

Executive Director

Ge Xinyu

Managing Director

Frank Hong

Managing Director

Henry Haiquan Ji

Executive Director

Yi Kang

Director

Jiaqing Li

Managing Director

Richard Li

President

Joon Park

Managing Director

Zhenxing Shao

Partner / Managing Director

Jenking Shao

Managing Director and Partner

Piau-Voon Wang

Managing Director

Jeff Wang

Managing Director

Junfeng Wang

Managing Director

Nengguang Wang

Managing Director and CFO

Tony Wang

Managing Director and Vice President

William Wen

Executive Director

Hank Zhou Ph.D

Managing Director and Co-Chief Investment Officer

Quan Zhou

Managing Director, Partner

Hongbin Zhou

Managing Director

Linan Zhu

Chairman

Past deals in Growth Stage

AiCheng Technology

Series B in 2025
Suzhou Aicheng Technology is an organization that seamlessly integrates research and development (R&D) with production processes.

Volant Aerotech

Series B in 2024
Volant Aerotech is a company specializing in the R&D, manufacturing, and service of passenger eVTOL, an electric vertical take-off and landing aircraft.

Angitia Biopharmaceuticals

Series C in 2024
Angitia Biopharmaceuticals is a global clinical-stage biotechnology company focused on discovering and developing therapeutics for musculoskeletal diseases, specifically targeting bone, muscle, and joint conditions. Through its research and development activities, it aims to deliver breakthrough therapies that address unmet needs and improve outcomes for patients with severe musculoskeletal disorders.

Hohem

Series B in 2024
Hohem is a camera gimbal developer specialized in the research, development, and design of drone flight control and image stabilization systems. Its key products are automatic face tracking shooting stabilizer, Bat vision positioning multi-rotor flight control system, Bfly multi-rotor flight control system, and Bee cross-country multi-rotor flight control system.

Nuwacell

Series B in 2024
Nuwacell focuses on the research and development, production and clinical transformation application of iPSC-derived cell therapy products.

Macrolux Medical

Series B in 2024
Macrolux Medical is a medical technology company that specializes in endoscopic interventional solutions. It focuses on developing devices for both diagnosis and treatment across various medical fields, including urology, respiratory, and digestive health. By promoting these innovative solutions to a wide range of medical customers, Macrolux aims to enhance patient outcomes through earlier detection and improved treatment options. The company's commitment to advancing endoscopic therapy positions it as a key player in the medical device sector.

RUICYCLE

Series C in 2024
RUICYCLE is a high-tech company dedicated to the comprehensive recycling and utilization of lithium batteries. The company develops innovative solutions for the recovery and regeneration of lithium battery materials, emphasizing cascade utilization and new material recycling. RUICYCLE's technologies enable an industrial ecological closed loop that ensures automatic, safe crushing of batteries, alongside zero pollution treatment and recycling solutions. Through its advanced methodologies, RUICYCLE aims to address the growing challenges associated with lithium battery waste and promote sustainability in the battery industry.

Dearer Medical

Series C in 2024
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company is dedicated to research and development in this field, focusing on both practical and fashionable color contact lens options. By combining innovation with quality manufacturing, Dearer Medical aims to meet the diverse needs of customers seeking enhanced vision solutions.

Leapstack

Series C in 2023
Leapstack is an insurance technology company founded in February 2016 and headquartered in Shanghai, with additional offices in Beijing and Nanjing. The company specializes in big data artificial intelligence solutions tailored for commercial insurance providers and social security management agencies. Leapstack develops a data analysis and management platform that enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, and anti-fraud compliance identification. By addressing inefficiencies within the insurance industry, Leapstack aims to improve operational effectiveness and facilitate better decision-making for its clients.

Angitia Biopharmaceuticals

Series B in 2023
Angitia Biopharmaceuticals is a global clinical-stage biotechnology company focused on discovering and developing therapeutics for musculoskeletal diseases, specifically targeting bone, muscle, and joint conditions. Through its research and development activities, it aims to deliver breakthrough therapies that address unmet needs and improve outcomes for patients with severe musculoskeletal disorders.

Saige Research

Series B in 2023
Saige Research specializes in AI solutions for industrial inspection and quality control. It offers a deep learning vision inspection platform tailored for manufacturers, enhancing inspector efficiency through power detection, speed detection, wide versatility, and convenient development.

Zhipu AI

Series B in 2023
Zhipu AI is a technology company specializing in developing large-scale artificial intelligence models. It offers API services powered by its General Language Model (GLM) series, designed to handle both Chinese and English tasks. The company's products include chatbots and advanced AI tools, aiming to reduce manual labor in digital tasks.

HC Scientific

Series B in 2023
HC Scientific (Chengdu) L.L.C., established in 2016, is a national high-tech enterprise focused on developing intelligent solutions in life technology. The company aims to empower life sciences through innovative products, including genetic testing instruments, reagents, and software, primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is committed to autonomous research and development of intellectual property and is recognized for its contributions to China's new economy development initiatives. The organization employs a team of experts, including returning PhDs and professors, who have developed advanced life science technology platforms. Through its diverse product pipeline, HC Scientific streamlines complex tasks for practitioners in the life science field, thereby creating substantial value for its partners and contributing to significant national and provincial scientific and technological projects.

Jinqirui Biology

Series C in 2023
Jinqirui Biology is a biotechnology company that focuses on the research and development, manufacturing, production & sales of vitro diagnostics equipment and reagents.

Tailan New Energy

Series B in 2023
Tailan New Energy is a company co-founded by lithium battery R&D experts, focusing on the technological development and industrialization of new solid-state lithium batteries and key lithium battery materials.

Open Source China

Series B in 2023
Open Source China is a prominent online community focused on open source software technology. It serves as a platform for IT developers to discover, utilize, and exchange open source technologies, facilitating collaboration and innovation within the field. The community offers a variety of resources, including open source software libraries, code sharing, discussion forums, collaborative translation, and blogs. Additionally, Open Source China provides support through technical questions and answers, as well as software information services, creating an environment conducive to the development and optimization of open source technologies for domestic developers.

Bio-Engine

Series C in 2023
Bio-Engine is a company based in Shanghai, China, focused on the research and development of veterinary biological products. Founded in 2014, Bio-Engine specializes in creating and producing antibodies, recombinant proteins, and vaccines for both humans and livestock using serum-free suspension culture technology for animal cells. The company's expertise extends to providing clinical trial services for pharmaceutical manufacturers and scientific research units.

TriApex

Series C in 2023
TriApex is an innovative CRO dedicated to providing disease-oriented one-stop solutions to enable R&D for global pharmaceutical enterprises and research institutions.

DentaFilm

Series B in 2023
DentaFilm is a provider of oral intelligent equipment and a full-chain platform (FICP), concentrating on the advancement of both digital cloud platforms and oral intelligent equipment. It focuses on oral equipment for data collection, data storage, data transmission, data management, and data applications, covering clinic 2D, and 3D image data, CAD/ CAM design, clinic ERP system, PMS, equipment IoT intelligent management.

Rongke Power

Series B in 2023
Rongke Power specializes in the development and manufacturing of vanadium redox flow batteries, focusing on safe and reliable energy storage solutions. The company offers a diverse range of products, including its VPower, TPower, and UPowertm lines, as well as container energy storage systems and comprehensive energy storage solutions. Rongke Power provides operation and maintenance services for power stations, empowering enterprises to create cleaner and more energy-efficient energy grids. With a commitment to independent intellectual property rights, the company positions itself as a key player in the energy storage industry.

Tripod Preclinical Research

Funding Round in 2023
Tripod Preclinical Research is a Contract Research Organization that specializes in preclinical research services tailored for the biopharmaceutical industry. The company offers a comprehensive range of services, including nonhuman primate disease models, pharmacological efficacy assessments, early drug evaluations, and GLP toxicology. Tripod is committed to supporting global pharmaceutical companies, research and development enterprises, and medical device manufacturers in the evaluation of new chemical entities, food additives, biologics, pesticides, veterinary drugs, and cosmetics. Additionally, the organization provides technology support in areas such as translational medicine, clinical trials, biological analysis, and the management of biological sample banks, ensuring that its clients have the necessary resources to advance their research and development efforts effectively.

ZStack

Series C in 2023
ZStack is a provider of cloud computing services focused on simplifying access to cloud solutions for enterprises. The company offers a range of products, including self-developed private and hybrid cloud solutions, mini hyper-converged machines, and a cloud management platform. Its services are designed to facilitate unified management of data center resources, encompassing computing, networking, and storage. ZStack has successfully served over 2,500 enterprise users and has established partnerships with over 250 cloud vendors across various sectors, including government, finance, education, internet, energy, and manufacturing. The company's mission is to promote inclusive cloud computing by reducing the barriers associated with cloud adoption.

SJ Semi

Series C in 2023
SJ Semi is a MEOL foundry focused on front-end wafer manufacturing and quality systems. The company specializes in bumping, Cu pillar, RDL, and testing services for 12" wafers while investing in R&D for fan-out, TSV, interposer, and 3D technologies. With over a decade of experience, SJ Semi aims to support advancements in the semiconductor market.

ProBio

Series C in 2023
ProBio Inc. is a one-stop biopharmaceutical R&D and production platform. It provides end-to-end services for cell and gene therapy drugs, vaccine and biopharmaceutical discovery, antibody protein drugs.

ClinBrain

Series C in 2022
ClinBrain is a company that focuses on healthcare big data services, specifically aimed at hospitals. It has developed a hospital information integration platform that digitizes and standardizes patient data alongside medical and clinical data. This integration is designed to facilitate medical research, improving the efficiency and effectiveness of data management in healthcare settings. By streamlining access to comprehensive patient information, ClinBrain aims to enhance the overall quality of medical research and healthcare delivery.

VectorBuilder

Series C in 2022
VectorBuilder is an online platform specializing in the development and optimization of gene delivery solutions, catering to both basic research and clinical applications. The platform enables researchers to design and order custom gene delivery vectors with ease, effectively simplifying the traditionally complex processes involved in vector construction and production. VectorBuilder offers a comprehensive array of contract research organization (CRO) services, including scientific research vector customization and clinical vector preparation. Additionally, the company provides advanced capabilities in gene delivery technologies and AAV capsid engineering, supported by extensive inventories and state-of-the-art facilities that comply with Good Manufacturing Practices (GMP). By streamlining the process of vector cloning and offering personalized solutions, VectorBuilder supports advancements in life sciences and drug development.

Shuhai Supply Chain

Series B in 2022
Shuhai Supply Chain Logistics is a leading supply chain service provider based in Beijing, China, established in June 2011. The company specializes in offering comprehensive supply chain solutions tailored for the food industry, particularly catering businesses. Its services encompass sales, procurement, production, quality assurance, warehousing, and transportation, ensuring that restaurant owners receive fresh and high-quality ingredients. Shuhai operates a nationwide modern cold chain logistics network and food processing plants, which positions it as a benchmark enterprise in the supply chain sector, recognized by both industry authorities and customers for its commitment to quality and reliability.

Leadrive

Series C in 2022
LEADRIVE is a technology company specializing in the research, development, production, and sales of drive solutions for new energy vehicles, as well as high-performance power semiconductor modules. The company designs and manufactures advanced motor controllers and proprietary power modules that have been adopted by over ten leading automotive manufacturers and Tier-1 suppliers for mass production. LEADRIVE is also engaged in enhancing the localization of power semiconductor modules, with ongoing certification processes for silicon carbide modules and electronic controls. Additionally, the company invests in innovative energy solutions, including wind, solar, and energy storage systems. In collaboration with Rohm Semiconductor from Japan, LEADRIVE has established a joint laboratory to develop various silicon carbide modules, focusing on improving efficiency through comprehensive simulation, testing, and development processes that span from device-level to vehicle-level applications.

APTBIO

Series B in 2022
APTBIO was initiated by Shanghai Institutes for Biological Sciences under Chinese Academy of Sciences in 2004, and is mainly engaged in the application of mass spectrometry technology. The so-called mass spectrometry technology is to measure the quality of protein molecules to carry out the identification of protein molecules, the modification of protein molecules and the study of protein molecule interactions.

RUICYCLE

Series B in 2022
RUICYCLE is a high-tech company dedicated to the comprehensive recycling and utilization of lithium batteries. The company develops innovative solutions for the recovery and regeneration of lithium battery materials, emphasizing cascade utilization and new material recycling. RUICYCLE's technologies enable an industrial ecological closed loop that ensures automatic, safe crushing of batteries, alongside zero pollution treatment and recycling solutions. Through its advanced methodologies, RUICYCLE aims to address the growing challenges associated with lithium battery waste and promote sustainability in the battery industry.

Tianfu

Series C in 2022
Nanjing Tianfu Software Co., Ltd. is a developer of custom software solutions and intelligent industrial software based in Nanjing, China. Founded in 2011, the company serves various industries, including turbomachinery, hydraulic construction, automotive, aerospace, and shipbuilding. Its offerings encompass a range of technical services, such as CAE pre- and post-processing development, special solver development, industrial design platform construction, and artificial intelligence platform development. Tianfu focuses on meeting the specific needs of its clients by providing tailored software solutions that enhance efficiency and innovation across different sectors.

Joymed Technology

Series B in 2022
Joymed Technology specializes in the research and development, registration, and manufacturing of medical devices, providing comprehensive solutions tailored for medical equipment businesses. The company focuses on delivering innovative and reliable technology while ensuring high-quality standards in its products. By offering services such as device design, risk management, marketing, and product verification and validation, Joymed Technology enables its clients to develop and launch safe and affordable medical products efficiently. The company aims to become a trusted partner for both domestic and international medical device firms, particularly assisting small and medium-sized enterprises in navigating the complexities of the medical product market. Through flexible collaboration and optimized design processes, Joymed Technology seeks to accelerate mutual growth with its customers.

TBSTest Technology

Venture Round in 2022
TBSTest Technology is a developer and manufacturer of semiconductor test equipment, focusing on integrated circuit automatic test equipment, ATE, and SOC test equipment. It provides testing solutions including hardware, software, test boards, and memory systems, and offers pre-sales and after-sales support. The company serves IC designers and producers as well as scientific research institutions and universities. Founded in 2017, it is based in Beijing with branch offices in Xi’an, Shanghai, and Suwon, South Korea.

Lipinyun

Series B in 2022
Lipinyun is a tencent strategic investment company. They offer a full-process intelligent sales model, from customer acquisition and screening to customer management and digital asset accumulation, for enterprises diverse sales ecology. Their integration solution helps enterprises realize the upgrade and iteration of digital business.

ZHIYI TECH

Series B in 2022
Zhiyi Tech develops a supply chain platform for intelligent clothing design. They offer services for digitalized trend forecasting, design selection, and supply chain organization. They provide clothing companies with core functions such as fashion trend prediction, design empowerment, and style recommendation, and expand to the downstream of the industrial chain via the SaaS portal, providing one-stop design and flexible production supply chain platform services.

Qingwei Intelligent Technology

Series B in 2022
Qingwei Intelligent Technologies creates artificial intelligence chips that may be reconfigured to improve energy efficiency. The company's chips are designed with low power consumption, intelligent speech and visual features in mind, providing customers with a better consumer electronics experience and application.

MediLink Therapeutics

Series B in 2022
MediLink Therapeutics is a China-based developer of antibody-drug conjugates (ADC) focused on cancer therapy. The company advances next-generation ADCs and aims to address unmet medical needs in China, while pursuing global value through multicenter clinical trials and cross-border collaborations. Its R&D center is in Suzhou.

Inceptio Technology

Series B in 2022
Inceptio Technology is a developer of autonomous driving heavy-duty trucks based in Shanghai, China, with additional research and development centers in Silicon Valley. Founded in 2018, the company aims to transform line-haul logistics by offering a nationwide freight network that enhances safety, efficiency, and cost-effectiveness for logistic customers. Its autonomous trucks leverage advanced artificial intelligence, new energy technology, and logistics big data to deliver innovative and reliable transportation solutions. By focusing on the integration of these technologies, Inceptio Technology is positioned to provide significant improvements in the logistics sector.

Zhipu AI

Series B in 2022
Zhipu AI is a technology company specializing in developing large-scale artificial intelligence models. It offers API services powered by its General Language Model (GLM) series, designed to handle both Chinese and English tasks. The company's products include chatbots and advanced AI tools, aiming to reduce manual labor in digital tasks.

Hoteam Software

Series C in 2022
Hoteam Software specializes in developing and implementing enterprise-level intelligent manufacturing solutions, primarily focusing on independent research and development of industrial software tailored for Chinese markets. The company offers a suite of services including CAD, CAM, CAPP, PDM, PLM, MES, WMS, SRM, and digital factory solutions, all centered around 3D software. Their platforms aim to enhance work efficiency and reduce costs for industrial enterprises by providing collaborative research and development opportunities.

Singlomics

Series B in 2022
Singlomics is a biotechnology company that leverages single-cell sequencing technology to develop innovative antibody drugs aimed at treating infectious diseases and cancers. The company focuses on the discovery and development of neutralizing antibodies, including DXP593 and DXP604, which serve as potential therapeutic solutions against COVID-19. By utilizing advanced sequencing techniques, Singlomics aims to enhance the efficacy of antibody treatments and address significant health challenges in infectious diseases and oncology.

Zshield

Series C in 2022
Zshield Inc. is a Beijing-based company specializing in cyberspace data security and big data business risk management. Established in 2014, it is recognized as the first high-tech firm in China to leverage big data technologies in addressing emerging information security vulnerabilities. Zshield develops advanced integrated information security solutions that utilize lightweight virtualization, deep learning, and big data analysis to provide effective monitoring of server and terminal security. Its offerings include a comprehensive information security platform and the AndunTM ZS-ISP, which supports both government and enterprise clients in navigating the complexities of modern computing environments, including cloud computing and mobile applications. As traditional security measures struggle to cope with new threats, Zshield's innovative approach aims to fortify businesses against the evolving landscape of information security challenges.

Beijing Tianxing

Series B in 2022
Beijing Tianxing is a clinical solutions company for sports medicine for implants, arthroscopy devices, and sports medicine equipment.

Leapstack

Series C in 2021
Leapstack is an insurance technology company founded in February 2016 and headquartered in Shanghai, with additional offices in Beijing and Nanjing. The company specializes in big data artificial intelligence solutions tailored for commercial insurance providers and social security management agencies. Leapstack develops a data analysis and management platform that enhances the insurance claims process by offering services such as risk control monitoring, post-medical reimbursement, and anti-fraud compliance identification. By addressing inefficiencies within the insurance industry, Leapstack aims to improve operational effectiveness and facilitate better decision-making for its clients.

Xbiome

Series B in 2021
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.

ColorTech Bio

Series B in 2021
ColorTech Bio researches and develops precision molecular diagnostic equipment. It offers medical devices to improve biotechnology services and solutions. ColorTech Bio was founded in 2018 and is based in Suzhou, China.

River Security

Series C in 2021
River Security is a cybersecurity company that specializes in fraud risk protection and innovative dynamic application security solutions. Founded in 2012 and headquartered in Shanghai, with additional offices in Beijing and Shenzhen, the company has developed cutting-edge active defense security technology after extensive research and development. This technology challenges traditional security paradigms that have been in place for over two decades, enabling more effective and timely defenses against a wide range of modern cyber threats. River Security's products include a dynamic security bot-gate that predicts server behavior by transforming the underlying code of web pages, thereby enhancing the protection of corporate website applications and safeguarding business data. The company's approach not only improves security measures but also reduces deployment and operational costs for users.

Jifan Biotechnology

Series B in 2021
Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.

LePure Biotech

Series B in 2021
LePure Biotech, established in 2011 and headquartered in Shanghai, China, operates within the biotechnology and pharmaceutical sectors. The company specializes in the development and manufacturing of disposable biopharmaceutical process equipment and consumables, primarily focusing on products that facilitate the storage, transportation, filling, and leak detection of samples related to biosimilars, vaccines, and other biopharmaceutical applications. Its core offering is a disposable storage bag designed to meet the specific needs of these processes. Recently, LePure Biotech completed a B+ round of financing, which aims to fund the development of innovative products, establish a research and development center in the United States, enhance supply chain integration, and expand its R&D operations both domestically and internationally.

ESWIN Computing

Series C in 2021
ESWIN Computing is a technology company focused on the research, development, and design of IoT chips and RISC-V computing architectures. It develops chips and related components for display devices and wearable devices, emphasizing the design, testing, and materials of IoT and human-computer interaction integrated circuits. The company provides chips used in artificial intelligence, Internet of Vehicles, displays, and wearable technologies, supporting applications across consumer electronics and smart devices.

Wuxi Biortus Biosciences

Series B in 2021
Wuxi Biortus Biosciences Co. Ltd. is a contract research organization based in Jiangyin, China, founded in 2009. The company specializes in providing research and development services to facilitate drug discovery. Its offerings include recombinant protein production, in vitro assays and screening, medicinal chemistry, structural biology, and target validation. Wuxi Biortus operates five advanced research platforms, including X-ray crystallography and cryo-electron microscopy, aimed at delivering high-quality R&D services to clients. The organization is known for its innovative approaches, with several techniques developed by its research team receiving patents. Wuxi Biortus is a subsidiary of Jiangsu Shuangliang Group Company Ltd.

ForQaly

Series B in 2021
ForQaly is a medical device company specializing in the development of minimally invasive ventricular assist devices aimed at treating heart failure. The company focuses on creating therapeutic solutions that enhance circulation for patients, ensuring affordability and ease of use for healthcare providers. By prioritizing small trauma and large auxiliary flow in its designs, ForQaly's products are intended to offer effective and accessible care for individuals suffering from heart-related conditions, ultimately improving patient outcomes and quality of life.

H.Extract

Series C in 2021
H.Extract is a company focused on research and development, promotion, and sales of pharmaceutical enterprise resource planning (ERP) solutions. As a leading brand in the domestic pharmaceutical distribution sector, H.Extract's Cloud ERP System, Romens, has established a significant presence, serving over 40,000 pharmacies across China. The company has formed strategic partnerships, notably with Tencent Cloud and WeChat Pay, to enhance the efficiency of the medicine distribution industry, particularly in pharmaceutical wholesale and chain drugstores. With 14 years of experience, H.Extract has developed a strong technical foundation and management expertise in the operation of chain drugstores, allowing it to expand its customer base to include major pharmaceutical entities such as Harbin Pharmaceutical Group and Sichuan Derentang.

HC Scientific

Series B in 2021
HC Scientific (Chengdu) L.L.C., established in 2016, is a national high-tech enterprise focused on developing intelligent solutions in life technology. The company aims to empower life sciences through innovative products, including genetic testing instruments, reagents, and software, primarily used in clinical molecular diagnostics, health gene testing, and agricultural molecular breeding. HC Scientific is committed to autonomous research and development of intellectual property and is recognized for its contributions to China's new economy development initiatives. The organization employs a team of experts, including returning PhDs and professors, who have developed advanced life science technology platforms. Through its diverse product pipeline, HC Scientific streamlines complex tasks for practitioners in the life science field, thereby creating substantial value for its partners and contributing to significant national and provincial scientific and technological projects.

LYNK Pharmaceuticals

Series B in 2021
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

Berry Oncology

Series B in 2021
Berry Oncology specializes in developing genetic diagnostic solutions for early detection and mid-to-late stage monitoring of various malignant tumors. Their offerings span from companion diagnostics to response monitoring and prognosis prediction for both targeted and immune therapies, aiming to enhance cancer prevention and tumor diagnosis globally. The company's primary mission is to facilitate early diagnosis and treatment of all tumors, ensuring precise care for patients. Berry Oncology aspires to become a global leader in early screening and diagnosis of tumors, particularly in China's tumor gene testing market.

QANDA(Mathpresso)

Series C in 2021
Mathpresso, Inc. is an educational technology company based in Seoul, South Korea, established in 2015. It operates Qanda, a data-driven platform that leverages artificial intelligence and optical character recognition (OCR) technology to assist students with their studies. Users can take a photo of a question or problem, which the platform then analyzes to provide solutions and explanations. Qanda covers a wide range of subjects, including mathematics, Korean history, social studies, and science. The platform is designed to facilitate learning by allowing students to engage with tutors and access answers in real time. As of this year, Qanda has attracted over one million users in South Korea, making it a significant resource for students seeking help with homework and exam preparation.

YEASEN Biotechnology

Series B in 2021
Yeasen is a biotechnology company that provides molecular enzymes, proteins, antibodies, nucleic acids, and cells. They produce fields of life science research, diagnosis and detection, and biomedicine.

Horizon Robotics

Series C in 2021
Horizon Robotics specializes in advanced driver-assistance systems (ADAS) and autonomous driving (AD) solutions for passenger vehicles. The company's offerings combine innovative algorithms, tailored software, and high-performance hardware to enhance safety and driving experience.

Bloks Technology Group

Series B in 2021
Bloks Group uses innovative technology to create the ultimate product experience and create long-term value for users. The group currently has four core business segments, including Bruker Building Blocks, Bruker Animation, Bubble Education, and Brock Education. Bloks Group strives to create a whole ecological industry chain with "building blocks +" as the core, and at the same time applies to build blocks to various application scenarios, and lays out a complete T (Toy toy) + A (Animation animation) + G (Game game) +E (Education Education) industry vision.

Dearer Medical

Series B in 2021
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company is dedicated to research and development in this field, focusing on both practical and fashionable color contact lens options. By combining innovation with quality manufacturing, Dearer Medical aims to meet the diverse needs of customers seeking enhanced vision solutions.

Fiture Technology

Series B in 2021
Fiture is a fitness technology company focused on transforming home fitness experiences through intelligent hardware and AI-driven content. The company offers customized online workout programs and manufactures advanced home workout equipment, utilizing artificial intelligence to enhance user engagement and effectiveness. By prioritizing the development of innovative solutions, Fiture aims to support clients in achieving their health and fitness goals from the comfort of their homes.

Stonewise

Series B in 2021
StoneWise is a technology company established in 2018 that focuses on accelerating novel drug discovery through the application of artificial intelligence. The company aims to revolutionize the traditional drug research and development process by introducing a dual-engine model that combines advanced AI technology with expert systems. Its platform incorporates cutting-edge technologies, including artificial intelligence and microfluidics, and integrates various fields such as computational chemistry, computational biology, pharmacology, and clinical medicine. StoneWise offers a comprehensive suite of services, including medical knowledge graphs, molecular generation and design, and predictions of reaction products, all designed to enhance the efficiency and success rates of early-stage drug discovery. The company collaborates with both domestic and international academic institutions, research organizations, and pharmaceutical manufacturers, and it is equipped with a state-of-the-art scientific facility to support its innovative initiatives in drug discovery.

Sciwind Biosciences

Series B in 2021
Hangzhou Sciwind Biosciences Co., Ltd. is a biotechnology company that focuses on the development and commercialization of protein and peptide-based drugs aimed at treating various diseases. Founded in 2017 and located in Hangzhou, China, the company targets multiple therapeutic areas, including diabetes, obesity, metabolic liver diseases, diabetic retinopathy, and neurodegenerative disorders. Sciwind's innovative drug candidates are particularly designed to address metabolic disorders, including non-alcoholic steatohepatitis, providing enhanced treatment options for physicians and their patients.

Liangyihui

Series C in 2021
Suzhou Liangyihui Network Technology Co., Ltd. is an authoritative anti-cancer academic platform based in Shanghai, China. The company focuses on addressing the information asymmetry prevalent in the oncology field by fostering long-term collaborations with various well-known hospitals and authoritative institutions both domestically and internationally. Liangyihui operates an online platform that provides comprehensive educational materials related to tumor treatment and oncology. This includes medical cases, conference information, online courses, and research reports, all aimed at offering reliable information and resources for oncologists, cancer researchers, and patients. The platform serves as a vital tool for promoting cancer prevention and treatment, thereby enhancing public awareness and understanding of cancer-related issues.

Exegenesis Bio

Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

Jinqirui Biology

Series B in 2020
Jinqirui Biology is a biotechnology company that focuses on the research and development, manufacturing, production & sales of vitro diagnostics equipment and reagents.

Wangdiantong

Series C in 2020
Wangdiantong is a provider of enterprise-level e-commerce solutions, specializing in retail cloud services that facilitate the digital transformation of businesses. The company offers a comprehensive ERP system that integrates with major online platforms such as Taobao, Tmall, and Amazon, among others. Its solutions encompass a wide range of functionalities, including inventory management, order processing, purchasing, after-sales support, accounts management, and customer relationship management (CRM). Additionally, Wangdiantong supports multi-warehouse operations and provides tools for managing both online and physical store cashiers. By leveraging intelligent warehouse and ERP solutions, the company aims to help businesses scale and achieve efficient, intelligent management practices in an increasingly digital marketplace.

Xbiome

Series B in 2020
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.

Kunya Medical

Series C in 2020
Kunya Medical is a provider of medical equipment management services, specializing in the maintenance, installation, and repair of hospital medical equipment. The company offers comprehensive outsourcing solutions that enhance the efficiency of medical equipment management within hospitals, thereby extending the lifecycle of critical clinical devices. Kunya Medical caters to both domestic and international brands of large and medium-sized medical equipment, delivering services such as technical maintenance, equipment relocation, installation, and debugging. Additionally, the company supplies a full range of spare parts and equipment management software, ensuring that hospitals can effectively manage their medical assets.

GalaxySpace

Series C in 2020
Founded in 2016, GalaxySpace specializes in developing and manufacturing low Earth orbit (LEO) broadband satellite constellations for global internet connectivity. Their satellite applications include monitoring services for airports, parking lots, oil reserves, and land use assessment.

Aqrose Technology

Series B in 2020
Aqrose Technology Co., Ltd., established in 2017 and originating from the AI Lab of Tsinghua University, specializes in integrating advanced artificial intelligence and machine vision technologies into industrial applications. The company develops products such as AIDI, a standardized intelligent industrial vision platform, and AIPICK, an intelligent inspecting and sorting robot that utilizes 3D vision technology. Aqrose's solutions are designed to enhance manufacturing processes and product quality across various sectors, including consumer electronics, automobiles, new energy, medicine, semiconductors, and logistics. Their innovations have been implemented in over 100 factories, serving prominent clients in advanced manufacturing and smart logistics, thereby contributing to increased efficiency and effectiveness in these industries.

Genskey

Series C in 2020
GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. The company utilizes high-throughput sequencing technology combined with intelligent algorithm analysis to address challenges associated with traditional diagnostic methods, such as low detection rates, lengthy processes, and accuracy issues. By improving the timeliness and precision of pathogen diagnosis, GensKey enables patients suffering from severe infections to receive prompt and reliable diagnoses, thereby enhancing the potential for effective treatment and recovery.

Hemu (China) Biological Engineering

Series B in 2020
Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.

HEMO BIOENGINEERING

Series B in 2020
HEMO BIOENGINEERING develops and provides innovative interventional medical devices to patients.

Leadrive

Series B in 2020
LEADRIVE is a technology company specializing in the research, development, production, and sales of drive solutions for new energy vehicles, as well as high-performance power semiconductor modules. The company designs and manufactures advanced motor controllers and proprietary power modules that have been adopted by over ten leading automotive manufacturers and Tier-1 suppliers for mass production. LEADRIVE is also engaged in enhancing the localization of power semiconductor modules, with ongoing certification processes for silicon carbide modules and electronic controls. Additionally, the company invests in innovative energy solutions, including wind, solar, and energy storage systems. In collaboration with Rohm Semiconductor from Japan, LEADRIVE has established a joint laboratory to develop various silicon carbide modules, focusing on improving efficiency through comprehensive simulation, testing, and development processes that span from device-level to vehicle-level applications.

HaiHe Biopharma

Series B in 2020
HaiHe Biopharma is a biotechnology company focused on developing innovative anti-tumor drugs to address complex diseases and advance pharmacological evaluation. It engages in discovery, development, and commercialization of anti-tumor therapies, conducts pharmacological efficacy evaluation, and offers products including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors, helping customers improve health outcomes and research quality.

Tongcheng Shenghuo

Series C in 2020
Tongcheng Life is a community O2O group purchase service platform. With the community as a unit, it establishes a community sales office and completes offline delivery. The platform provides supply, logistics, storage and after-sales support. It mainly provides primary edible agricultural products, food, daily necessities, flowers and gardening, and crafts. , Beauty products and other services.

ESWIN Computing

Series B in 2020
ESWIN Computing is a technology company focused on the research, development, and design of IoT chips and RISC-V computing architectures. It develops chips and related components for display devices and wearable devices, emphasizing the design, testing, and materials of IoT and human-computer interaction integrated circuits. The company provides chips used in artificial intelligence, Internet of Vehicles, displays, and wearable technologies, supporting applications across consumer electronics and smart devices.

Uditech

Series B in 2020
Uditech is a high-tech enterprise with technology as its core and innovation-oriented.

iBeiDiao

Series B in 2020
iBeiDiao offers intelligent employee background investigation services. It uses AI to provide objective checks and streamline onboarding processes, delivering reliable credit reference data to help businesses make informed hiring decisions.

Wangdiantong

Series B in 2020
Wangdiantong is a provider of enterprise-level e-commerce solutions, specializing in retail cloud services that facilitate the digital transformation of businesses. The company offers a comprehensive ERP system that integrates with major online platforms such as Taobao, Tmall, and Amazon, among others. Its solutions encompass a wide range of functionalities, including inventory management, order processing, purchasing, after-sales support, accounts management, and customer relationship management (CRM). Additionally, Wangdiantong supports multi-warehouse operations and provides tools for managing both online and physical store cashiers. By leveraging intelligent warehouse and ERP solutions, the company aims to help businesses scale and achieve efficient, intelligent management practices in an increasingly digital marketplace.

Healing Paper

Series B in 2020
Healing Paper leverages information technology to enhance accessibility to medical services, reduce costs, and facilitate balanced communication between healthcare professionals and non-experts.

ANYCOLOR

Post in 2020
ANYCOLOR is a start-up in the entertainment industry, specializing in supporting and managing virtual talent, notably the Nijisanji Project. They facilitate the operation of virtual talents, known as "virtual rivers," within this project. The company leverages advanced technology to create innovative experiences for global audiences, aiming to enrich everyday lives through its unique offerings.

Harbour BioMed

Series B in 2020
Harbour BioMed is a biotechnology company focused on discovering and developing therapeutics for cancer and inflammatory diseases. Established in 2016 with operations in Shanghai, Cambridge, and Rotterdam, the company leverages its proprietary transgenic mouse platforms to generate fully human monoclonal antibodies (H2L2) and heavy chain only antibodies (HCAb), enabling the development of differentiated compounds such as bi-specific and multi-specific antibodies. Harbour BioMed collaborates strategically with various institutions and companies, including The Wistar Institute, WuXi Biologics, and Vir Biotechnology, to advance its pipeline of therapeutics targeting autoimmune diseases, dry eye disease, COVID-19, and other indications.

Genskey

Series B in 2020
GensKey is a medical diagnostic service provider specializing in genetic testing for pathogen diagnosis. The company utilizes high-throughput sequencing technology combined with intelligent algorithm analysis to address challenges associated with traditional diagnostic methods, such as low detection rates, lengthy processes, and accuracy issues. By improving the timeliness and precision of pathogen diagnosis, GensKey enables patients suffering from severe infections to receive prompt and reliable diagnoses, thereby enhancing the potential for effective treatment and recovery.

Lunit

Series C in 2019
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.

Nanovision

Series B in 2019
Nanovision Technology, based in the Zhongguancun Yongfeng high-tech industrial base, specializes in high-speed and high-precision radiology imaging solutions. With a significant research and development presence in Yonyou Industrial Park and a subsidiary in Chengdu, the company focuses on static computed tomography (CT), X-ray CMOS detectors, and X-ray imaging software. Notably, Nanovision developed China's first self-designed CMOS flat panel detector, known as the Merak series, which serves a diverse range of applications across medical, industrial, and security sectors. By providing advanced technological support both domestically and internationally, Nanovision aims to enhance imaging capabilities in various fields.

Dongfang Weiyin

Series C in 2019
Dongfang Weiyin is a small and micro enterprise financial service platform.

Suzhou Ribo Life Science

Series C in 2019
Suzhou Ribo Life Science focuses on developing nucleic acid therapeutics using RNA interference (RNAi) technology. The company advances RNAi-based drug discovery, including siRNA design and screening, chemical modification and delivery technologies, and pharmacokinetic and safety evaluation, through to clinical trials. It targets liver-related diseases, including Hepatitis B, liver fibrosis and liver cancer, as well as breast cancer and HIV. The company operates from Kunshan, China, and was founded in 2007. It has pursued strategic partnerships, notably with Quark Pharmaceuticals, to advance its RNAi programs.

RT-Thread

Series B in 2019
RT-Thread is a Shanghai-based company founded in 2006 that specializes in developing an open-source real-time operating system (RTOS) designed for embedded devices. The RT-Thread operating system supports a range of features suitable for the Internet of Things (IoT), including cross-chip platform compatibility, real-time kernel capabilities, cloud integration, and ultra-low power design. The system is available in two versions: a Standard version for resource-rich IoT devices, and a Nano version tailored for resource-constrained microcontroller systems, requiring minimal memory resources. RT-Thread employs object-oriented programming techniques to ensure that its code is elegant, modular, and easily customizable. Its offerings include a suite of functionalities such as a device virtual file system, device management framework, low-power management, and support for firmware remote upgrades. The company serves various industries, including new energy, home appliances, and transportation, facilitating seamless connectivity and operational efficiency across IoT applications.

Xbiome

Series B in 2019
Xbiome Co. Ltd., established in 2017 and headquartered in Shenzhen, China, is an AI-based microbiome drug development company. It specializes in the analysis of patient and donor intestinal flora using artificial intelligence to accelerate the development of effective pharmaceuticals for microecological intestinal disorders. Xbiome's products focus on micro-ecological treatment, aiming to manage the gut health of a vast population.

Gambol Pet Group

Series B in 2019
Gambol Pet Group Co., Ltd is a prominent manufacturer of pet food, specializing in a diverse array of products including dry and wet food, real meat jerky treats, rawhide chews, and dental bones. Founded in 2006 and headquartered in Liaocheng City, China, the company focuses on the research, development, production, and sales of various pet food categories. Its offerings encompass pet treats made from chicken, duck, pork, lamb, and fish, as well as dog food enriched with nutritional supplements and natural ingredients. Gambol Pet Group serves a wide customer base across Europe, Asia, and North America, demonstrating its international reach and commitment to quality in pet nutrition. The company is led by Chairman and CEO Qin Hua.

dMed

Series B in 2019
dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.

QANDA(Mathpresso)

Series B in 2019
Mathpresso, Inc. is an educational technology company based in Seoul, South Korea, established in 2015. It operates Qanda, a data-driven platform that leverages artificial intelligence and optical character recognition (OCR) technology to assist students with their studies. Users can take a photo of a question or problem, which the platform then analyzes to provide solutions and explanations. Qanda covers a wide range of subjects, including mathematics, Korean history, social studies, and science. The platform is designed to facilitate learning by allowing students to engage with tutors and access answers in real time. As of this year, Qanda has attracted over one million users in South Korea, making it a significant resource for students seeking help with homework and exam preparation.

GalaxySpace

Series B in 2019
Founded in 2016, GalaxySpace specializes in developing and manufacturing low Earth orbit (LEO) broadband satellite constellations for global internet connectivity. Their satellite applications include monitoring services for airports, parking lots, oil reserves, and land use assessment.

GKHT Medical Technology

Series C in 2019
Guoke Hengtai (Beijing) Medical Technology Co., Ltd. is a Chinese company established in February 2013 and headquartered in the Yizhuang Economic and Technological Development Zone of Beijing. It operates under the umbrella of Oriental Science and Technology Holding Group Co., Ltd., which is connected to the State-owned Assets Supervision and Administration Commission of the Chinese Academy of Sciences. GKHT Medical Technology specializes in the distribution and direct sales of medical devices, offering a range of professional services, including warehousing logistics, distribution channel management, and hospital SPD operation management. Since its inception, the company has demonstrated significant growth, achieving a compound annual growth rate of over 50%, and it is currently pursuing an initial public offering.

AgotoZ

Series B in 2019
AgotoZ Technology, established in 2017, specializes in high-speed network transmission solutions for enterprises. The company, operating under Guanmai Technology (Beijing) Co., Ltd., focuses on developing advanced technologies in WAN transmission, big data computing, and security defense. AgotoZ aims to enhance enterprise performance by providing an efficient interoperability platform and related solutions, ensuring that businesses can effectively meet their network transmission needs. Through independent research and development, AgotoZ continues to innovate its core technologies and products, positioning itself as a leader in the field of intelligent network transmission.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.